WO2002002092A3 - Compositions based on aminoacids, suitable for improving muscle performance - Google Patents

Compositions based on aminoacids, suitable for improving muscle performance Download PDF

Info

Publication number
WO2002002092A3
WO2002002092A3 PCT/IB2001/001182 IB0101182W WO0202092A3 WO 2002002092 A3 WO2002002092 A3 WO 2002002092A3 IB 0101182 W IB0101182 W IB 0101182W WO 0202092 A3 WO0202092 A3 WO 0202092A3
Authority
WO
WIPO (PCT)
Prior art keywords
amino acids
active ingredients
compositions based
improving muscle
aminoacids
Prior art date
Application number
PCT/IB2001/001182
Other languages
French (fr)
Other versions
WO2002002092A2 (en
Inventor
Francesco Saverio Dioguardi
Original Assignee
Professional Dietetics Srl
Francesco Saverio Dioguardi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Dietetics Srl, Francesco Saverio Dioguardi filed Critical Professional Dietetics Srl
Priority to AU2001274422A priority Critical patent/AU2001274422A1/en
Priority to EP01940936A priority patent/EP1296668A2/en
Priority to US10/332,237 priority patent/US20030187049A1/en
Publication of WO2002002092A2 publication Critical patent/WO2002002092A2/en
Publication of WO2002002092A3 publication Critical patent/WO2002002092A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Compositions based on amino acids are described, in particular for oral or parenteral use, suitable for improving muscle performances. The compositions according to the invention comprise up to 75% of the branched chain amino acids leucine, isoleucine and valine, as active ingredients. Preferably, the compositions also comprise, as further active ingredients, up to 50% of threonine and lysine. Other essential amino acids are preferably also provided (in particular methionine, phenylalanine, histidine, triphtophan) as well as non essential amino acids (in particular tyrosine and/or cyst(e)ine-i.e. cystine and cyst(e)ine). Other amino acids can be added, provided that their sum is in a percentage being lower than 20% with respect to the other active ingredients, and less than 10% for each single amino acid.
PCT/IB2001/001182 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance WO2002002092A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001274422A AU2001274422A1 (en) 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance
EP01940936A EP1296668A2 (en) 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance
US10/332,237 US20030187049A1 (en) 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITTO2000A000675 2000-07-04
IT2000TO000675A IT1320783B1 (en) 2000-07-04 2000-07-04 COMPOSITIONS BASED ON AMINO ACIDS, SUITABLE TO IMPROVE MUSCLE PERFORMANCE.

Publications (2)

Publication Number Publication Date
WO2002002092A2 WO2002002092A2 (en) 2002-01-10
WO2002002092A3 true WO2002002092A3 (en) 2002-06-20

Family

ID=11457894

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/001182 WO2002002092A2 (en) 2000-07-04 2001-06-28 Compositions based on aminoacids, suitable for improving muscle performance

Country Status (4)

Country Link
EP (1) EP1296668A2 (en)
AU (1) AU2001274422A1 (en)
IT (1) IT1320783B1 (en)
WO (1) WO2002002092A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20010580A1 (en) * 2001-06-15 2002-12-15 Professional Dietetics Srl AMINO ACID BASED COMPOSITIONS FOR IMPROVING THE MYOCARDIC VENTRICULAR FUNCTION IN PATIENTS WITH DIABETES.
GB2394698A (en) 2002-11-01 2004-05-05 Gibbs Tech Ltd Amphibious vehicle wheel transmission arrangement
IT1397023B1 (en) * 2009-11-27 2012-12-20 Professional Dietetics Srl COMPOSITIONS INCLUDING AMINO ACIDS, FOR THE TREATMENT OF CHRONIC OSTRUCTIVE BRONCOPNEUMOPATHY
IT1397446B1 (en) * 2010-01-12 2013-01-10 Professional Dietetics Srl COMPOSITIONS COMPRISING AMINO ACIDS FOR PREVENTION AND / OR TREATMENT OF RENAL DISORDERS.
NO3006027T3 (en) * 2014-10-08 2018-04-14
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
CU20200012A7 (en) 2017-08-14 2021-02-04 Axcella Health Inc AMINO ACID COMPOSITIONS FOR THE TREATMENT OF LIVER DISEASE
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
IT202000021664A1 (en) * 2020-09-14 2022-03-14 Iaf Network S P A BALANCED AMINO ACID FORMULATION

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
WO1998026774A1 (en) * 1996-12-16 1998-06-25 Professional Dietetics S.R.L. Compositions based on aminoacids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
WO1998026774A1 (en) * 1996-12-16 1998-06-25 Professional Dietetics S.R.L. Compositions based on aminoacids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Guide National de Préscription des Médicaments", 1994, EDITIONS DU VIDAL, PARIS, XP002185101 *

Also Published As

Publication number Publication date
WO2002002092A2 (en) 2002-01-10
ITTO20000675A1 (en) 2002-01-04
EP1296668A2 (en) 2003-04-02
ITTO20000675A0 (en) 2000-07-04
IT1320783B1 (en) 2003-12-10
AU2001274422A1 (en) 2002-01-14

Similar Documents

Publication Publication Date Title
WO2006029411A3 (en) Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
WO2006105112A3 (en) Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people
CA2242646A1 (en) Amino acid composition
WO2005034932A3 (en) Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
CY1115918T1 (en) COMPOSITIONS BASED ON BRANCHED AMINOXY CHAIN FOR IMPROVING MYCARDIAL CYCLIC FUNCTION IN PATIENTS WITH PATIENTS
WO2002002092A3 (en) Compositions based on aminoacids, suitable for improving muscle performance
WO2009057775A1 (en) Anti-fatigue agent comprising amino acid composition
WO2007133642A8 (en) Sport drink containing amino acids and carbohydrates
WO2001003684A3 (en) Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
WO2002002103A3 (en) Compositions based on aminoacids, suitable for the treatment of heart failure
DE69728163D1 (en) COMPOSITION OF AMINO ACIDS
CA2455776A1 (en) Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
JP2004534073A5 (en)
WO2001005383A3 (en) Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine
CA2782169A1 (en) Compositions comprising amino acids for treating chronic obstructive pulmonary disease
WO2004043141A3 (en) Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
CA2091602A1 (en) Highly concentrated amino acid solution
DE60323164D1 (en) ARGININE / LYSIN-ENRICHED PEPTIDE
EP0506653A1 (en) Amino acid composition
NO964815D0 (en) nutritional Formulation
ES2126516A1 (en) Glycoprotein for the protection of liposomes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10332237

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001940936

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001940936

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001940936

Country of ref document: EP